Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4463027
Max Phase: Preclinical
Molecular Formula: C28H30F6N4O10S3
Molecular Weight: 678.73
Molecule Type: Unknown
Associated Items:
ID: ALA4463027
Max Phase: Preclinical
Molecular Formula: C28H30F6N4O10S3
Molecular Weight: 678.73
Molecule Type: Unknown
Associated Items:
Canonical SMILES: N[C@@H](CC(=O)NC1(c2nc3ccc(OCC(=O)NCCS(=O)(=O)O)cc3s2)CCS(=O)(=O)CC1)Cc1cc(F)c(F)cc1F.O=C(O)C(F)(F)F
Standard InChI: InChI=1S/C26H29F3N4O8S3.C2HF3O2/c27-18-13-20(29)19(28)10-15(18)9-16(30)11-23(34)33-26(3-6-43(36,37)7-4-26)25-32-21-2-1-17(12-22(21)42-25)41-14-24(35)31-5-8-44(38,39)40;3-2(4,5)1(6)7/h1-2,10,12-13,16H,3-9,11,14,30H2,(H,31,35)(H,33,34)(H,38,39,40);(H,6,7)/t16-;/m1./s1
Standard InChI Key: JXIGIFSXLAAYEF-PKLMIRHRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 678.73 | Molecular Weight (Monoisotopic): 678.1100 | AlogP: 1.58 | #Rotatable Bonds: 12 |
Polar Surface Area: 194.85 | Molecular Species: ACID | HBA: 10 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 12 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: -1.29 | CX Basic pKa: 8.38 | CX LogP: -1.24 | CX LogD: -1.28 |
Aromatic Rings: 3 | Heavy Atoms: 44 | QED Weighted: 0.16 | Np Likeness Score: -1.17 |
1. Huang F, Ning M, Wang K, Liu J, Guan W, Leng Y, Shen J.. (2019) Discovery of Highly Polar β-Homophenylalanine Derivatives as Nonsystemic Intestine-Targeted Dipeptidyl Peptidase IV Inhibitors., 62 (23): [PMID:31747282] [10.1021/acs.jmedchem.9b01649] |
Source(1):